Scleroderma-like reaction induced by uracil-tegafur (UFT), a second-generation anticancer agent.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 10688731.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
UFT, a combination of uracil and tegafur, is a second-generation anticancer agent. UFT has been used in Japan, other Asian countries, South America, and Russia. Recently, UFT has been extensively studied for colorectal, pancreatic, and various types of cancer in North America and Europe, especially with leukovorin. We report a case of a scleroderma-like reaction induced by long-term administration of UFT. This is the first report of UFT-induced scleroderma-like reaction.
Medical subject headings
- Antimetabolites, Antineoplastic
- Antineoplastic Combined Chemotherapy Protocols
- Scleroderma, Systemic
- Tegafur
- Uracil